Peritoneal Dialysis Market Size, Share, Growth Analysis, By Product Type(CAPD, APD), By Product(Cyclers, Fluids), By End User(Home Health Care, Hospitals), By Region - Industry Forecast 2024-2031

Peritoneal Dialysis Market size was valued at USD 76.9 billion in 2019 and is poised to grow from USD 81.8 billion in 2023 to USD 126.43 billion by 2031, growing at a CAGR of 6.4% in the forecast period (2024-2031).

The peritoneal dialysis market is relatively fragmented, with a high level of competition. The prominent players operating in the market are constantly adopting various growth strategies to stay afloat in the market. Product launches, innovations, mergers, and acquisitions, collaborations and partnerships, and intensive R&D are some of the growth strategies that are adopted by these key players to thrive in the competitive market. For example, to enhance the patient treatment experience and for better overall results, Medtronic, a pioneer in healthcare technology, has partnered with DaVita's extensive experience as a provider of comprehensive kidney care. Together, they plan to establish a new independent medical device company called "NewCo," with a focus on kidneys. For patients with renal failure, NewCo will be positioned as an advanced firm of discovery and distinctive therapeutics. The key market players are also constantly focused on R&D to supply industries with the most efficient and cost-effective solutions. ' Baxter B. Braun Melsungen AG Fresenius Medical Care AG & Co. KGaA Medtronic plc Terumo Corporation Cook Medical Inc. Utah Medical Products Inc. Cardinal Health Inc. Poly Medicure Limited Diversified Specialty Institute Holdings Inc. Renax Biomedical Tech Co. Ltd. Renal Solutions Inc. Vygon SA Merit Medical Systems Inc. Huaren Pharmaceutical Co. Ltd. Nikkiso Co. Ltd. Nephros Inc. Covidien plc AngioDynamics Inc. Q Core Medical Ltd. ', 'Baxter', 'B. Braun Melsungen AG', 'Fresenius Medical Care AG & Co. KGaA', 'Medtronic plc', 'Terumo Corporation', 'Cook Medical Inc.', 'Utah Medical Products Inc.', 'Cardinal Health Inc.', 'Poly Medicure Limited', 'Diversified Specialty Institute Holdings Inc.', 'Renax Biomedical Tech Co. Ltd.', 'Renal Solutions Inc.', 'Vygon SA', 'Merit Medical Systems Inc.', 'Huaren Pharmaceutical Co. Ltd.', 'Nikkiso Co. Ltd.', 'Nephros Inc.', 'Covidien plc', 'AngioDynamics Inc.', 'Q Core Medical Ltd.'

During the projected period, factors like rising end-stage renal disease (ESRD) prevalence, technical advancements in peritoneal dialysis cyclers, and rising demand for home dialysis treatment is anticipated to propel the growth of the peritoneal dialysis market. Peritoneal dialysis also has several benefits, including lower costs compared to hemodialysis, needle-free therapy, mobility, ease of treatment, and fewer dietary restrictions, which all contribute to the market's expansion internationally.

The primary growth drivers of the peritoneal dialysis market are increase in the prevalence of End Stage Renal Disease (ESRD), increase in the number of patients with acute diabetes and high blood pressure, increased public awareness of peritoneal dialysis, increased government initiatives globally, and an increase in the demand for technologically advanced treatment methods. Additionally, growing peritoneal dialysis use in developing nations like China, India, and others would open up new prospects for the peritoneal dialysis market.

With a market share of more than 35.0 percent and the highest revenue in 2021, North America dominated the peritoneal dialysis market. The region's market is expanding as a result of the existence of important players, large government expenditures in the creation of cutting-edge medical devices, and a favorable reimbursement environment. Dialysis is becoming more popular as a result of the increase in kidney failures and chronic kidney diseases (CKD). High disposable income, government efforts, and rising healthcare spending are a few major reasons boosting the industry.